Medpace Q2 FY26 GAAP net income rises 34.4% to $121.4 million; revenue climbs 17.2% to $707.3 million - MEDP News | RalliesMedpace Q2 FY26 GAAP net income rises 34.4% to $121.4 million; revenue climbs 17.2% to $707.3 million
M
MEDP• Second-quarter results
- Medpace posted Q2 revenue of $707.3 million, up 17.2% from the year-earlier period, with a 24.1% backlog conversion rate.
- GAAP net income rose to $121.4 million, or $4.25 per diluted share, lifting net margin by 2.2 percentage points to 17.2%.
- Net new business awards climbed 28.2% to $795.7 million, driving a net book-to-bill ratio of 1.13x; backlog increased 4.9% to $3.01 billion.
2026 outlook
- Medpace forecast 2026 revenue of $2.81 billion to $2.89 billion, with GAAP net income of $494 million to $514 million.
